Brief: Strides Pharma Science Got Tentative USFDA Approval For Dolutegravir/ Lamivudine/ Tenofovir Disproxil Fumurate Tablets
Sept 15 (Reuters) - Strides Pharma Science Ltd
SRID.NS :
* STRIDES PHARMA SCIENCE LTD - RECEIVES TENTATIVE USFDA
APPROVAL
FOR DOLUTEGRAVIR/ LAMIVUDINE/ TENOFOVIR DISPROXIL FUMURATE
TABLETS
Source text for Eikon: ID:nNSE3gyJJ1
Further company coverage: SRID.NS
((reuters.briefs@thomsonreuters.com;))
Recent news on Strides Pharma Science
See all newsIndia's Strides Pharma jumps on successful closure of USFDA inspection at Bengaluru facility
Brief: Strides Pharma Science Receives USFDA EIR For Flagship Facility In Bengaluru
Brief: Strides Pharma Science Receives US FDA Establishment Inspection Report For Bengaluru Facility
Brief: Strides Pharma Science June-Quarter Consol Net Profit 1.57 Billion Rupees
Brief: Strides Pharma Science March-Quarter Consol Net Profit 1.27 Billion Rupees